AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 81 filers reported holding AVROBIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $2,825,000 | +1341.3% | 732,832 | +3226.5% | 0.00% | – |
Q2 2021 | $196,000 | -95.2% | 22,030 | -93.1% | 0.00% | -100.0% |
Q1 2021 | $4,069,000 | +159.3% | 320,993 | +185.6% | 0.00% | +100.0% |
Q4 2020 | $1,569,000 | +88.1% | 112,382 | +75.8% | 0.00% | – |
Q3 2020 | $834,000 | – | 63,937 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |